A detailed history of Parallel Advisors, LLC transactions in Insmed Inc stock. As of the latest transaction made, Parallel Advisors, LLC holds 1,914 shares of INSM stock, worth $141,348. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,914
Previous 1,874 2.13%
Holding current value
$141,348
Previous $125,000 11.2%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$62.0 - $79.01 $2,480 - $3,160
40 Added 2.13%
1,914 $139,000
Q2 2024

Aug 08, 2024

BUY
$22.0 - $69.71 $25,146 - $79,678
1,143 Added 156.36%
1,874 $125,000
Q1 2024

May 06, 2024

BUY
$25.72 - $29.94 $2,469 - $2,874
96 Added 15.12%
731 $19,000
Q4 2023

Feb 09, 2024

BUY
$23.42 - $31.74 $7,705 - $10,442
329 Added 107.52%
635 $19,000
Q3 2023

May 20, 2024

SELL
$19.86 - $26.93 $8,440 - $11,445
-425 Reduced 58.14%
306 $7,000
Q3 2023

Nov 13, 2023

BUY
$19.86 - $26.93 $6,077 - $8,240
306 New
306 $7,000
Q3 2022

Nov 10, 2022

BUY
$20.88 - $28.21 $480 - $648
23 Added 460.0%
28 $1,000
Q2 2022

Aug 01, 2022

BUY
$17.07 - $25.71 $85 - $128
5 New
5 $0
Q1 2022

Apr 28, 2022

SELL
$20.42 - $28.13 $2,429 - $3,347
-119 Closed
0 $0
Q4 2021

Jan 20, 2022

BUY
$25.89 - $33.45 $647 - $836
25 Added 26.6%
119 $3,000
Q2 2020

Jul 16, 2020

BUY
$14.11 - $29.42 $1,326 - $2,765
94 New
94 $2,000
Q4 2019

Jan 30, 2020

SELL
$16.12 - $24.98 $660 - $1,024
-41 Closed
0 $0
Q2 2019

Aug 05, 2019

BUY
$23.0 - $32.19 $943 - $1,319
41 New
41 $1,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.